{
    "Trade/Device Name(s)": [
        "Tina-Quant IgG Gen.2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K050113",
    "Predicate Device Reference 510(k) Number(s)": [
        "K943997",
        "K040434"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DEW"
    ],
    "Summary Letter Date": "March 2, 2005",
    "Summary Letter Received Date": "January 18, 2005",
    "Submission Date": "January 14, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, E Immunological Test"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Immunoglobulin G (IgG)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Cerebrospinal fluid (CSF)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche automated clinical chemistry analyzers",
        "Roche/Hitachi family of analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetric measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Tina-Quant IgG Gen.2 immunoturbidimetric assay for quantitative measurement of IgG in serum, plasma, and CSF on Roche analyzers",
    "Indications for Use Summary": "Immunoturbidimetric assay for quantitative in vitro determination of IgG in human serum, plasma and CSF on Roche automated analyzers; aids in diagnosis of abnormal protein metabolism and reduced resistance to infections",
    "fda_folder": "Immunology"
}